Appointment New Patient Appointment or 214-645-8300


All Cystic Fibrosis

Discovery; Transplant

Cystic fibrosis breakthrough: 3-drug combo pill may benefit 90% of patients

A new 3-drug combo drug for cystic fibrosis has been approved by the FDA. TRIKAFTA offers life-changing treatment potential for approximately 90% of patients with the disease. In this MedBlog, discover who is eligible and how the drug works. Learn more.

Digestive; Nutrition

Why isn’t my child gaining weight? 3 factors that can cause 'failure to thrive'

Babies and children who don't get proper nutrition can develop failure to thrive, a condition that causes delayed growth and poor brain development. In this MedBlog, find three common causes and strategies families can use to improve their child's health. Learn more.


Beyond the lungs: How CFTR modulators benefit cystic fibrosis patients

Traditionally, patients with cystic fibrosis have been treated with inhaled medications that could affect the lungs with limited systemic effects. However, a relatively new set of drugs, CFTR modulators, offer an oral alternative with the potential to slow the progression of the disease for up to 90 percent of patients.